Etoposide and doxorubicin enhance the sensitivity of triple negative breast cancers through modulation of TRAIL-DR5 axis
Crossref DOI link: https://doi.org/10.1007/s10495-017-1400-4
Published Online: 2017-07-12
Published Print: 2017-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Das, Sarita
Tripathi, Neha
Siddharth, Sumit
Nayak, Anmada
Nayak, Deepika
Sethy, Chinmayee
Bharatam, Prasad V.
Kundu, Chanakya Nath
License valid from 2017-07-12